Myriad Genetics | MYGN - Market Capitalization


Myriad Genetics reported $377.5M in Market Capitalization this October of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agilent USD 39.08B 6.43B Jun/2026
Becton, Dickinson and Co. USD 41.7B 3.07B Jun/2026
Bio-Rad Laboratories USD 7.87B 390M Jun/2026
Bruker USD 9.16B 3.66B Jun/2026
Danaher USD 138.86B 10.4B Jun/2026
Illumina USD 26.71B 8.84B Jun/2026
J&J USD 611.36B 32.21B Jun/2026
Mettler Toledo International USD 25.82B 278M Jun/2026
OraSure Technologies USD 174M 61M Dec/2025
Pacific Biosciences Of California USD 565M 180M Dec/2025
Quest Diagnostics USD 23.46B 1.77B Jun/2026
Quidel USD 940M 66M Jun/2026
Repligen USD 7.7B 1.05B Jun/2026
Revvity USD 12.69B 2.75B Jun/2026
Standard Biotools USD 359M 133M Mar/2026
Thermo Fisher Scientific USD 190.65B 7.99B Jun/2026
Veracyte USD 4.69B 2.12B Jun/2026
Waters USD 37.24B 7.38B Jun/2026